Recruiting NA Autism Spectrum Disorder

New treatment option for Autism Spectrum Disorder

Official title Auricular Transcutaneous Electrical Nerve Stimulation Treatment of Autism

ClinicalTrials.gov ID: NCT03827941

What this study is testing

What it's testing
In this study, investigators will examine the treatment effects of transcutaneous electrical nerve stimulation with different stimulation frequencies on individuals with autism.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 60

You may be able to join if

  • Autism diagnosed based on DSM-V classification criteria
  • 18-60 year old high functioning adult autism patients (e.g. Asperger's, IQ equal or greater than 80)
  • people who do not show aggressive behaviors based on neuro/psychiatric evaluations as determined by a licensed study physician.

You likely can't join if

  • A history of chronic serious infection, any current infection, any type of cancer or autoimmune disease or other severe diseases;
  • people taking any medications that confound the study results

The study team makes the final eligibility decision.

Where it's taking place

  • Charlestown, Massachusetts, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 60 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Charlestown, Massachusetts, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.